Minova Life Science

Minoclav-DS Dry Syrup

๐Ÿ”ฌ Introduction Minoclav-DS Dry Syrup is a higher-strength pediatric antibiotic designed for moderate to severe bacterial infections. It combines Amoxycillin, a broad-spectrum beta-lactam antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor, ensuring enhanced efficacy against resistant bacteria. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Amoxycillin Bioavailability: ~70-90%โœ” Peak Plasma Concentration: Within 1-2 hoursโœ” Protein Binding: ~18%โœ” Half-life: ~1-1.5 […]

Minoclav-DS Dry Syrup Read More ยป

Minoclav Dry Syrup

๐Ÿ”ฌ Introduction Minoclav Dry Syrup is a broad-spectrum antibiotic designed for pediatric infections. It combines Amoxycillin, a beta-lactam antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor, ensuring enhanced effectiveness against resistant bacterial infections. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Amoxycillin Bioavailability: ~70-90%โœ” Peak Plasma Concentration: 1-2 hours after administrationโœ” Protein Binding: ~18%โœ” Half-life: ~1-1.5 hoursโœ” Excretion: Renal

Minoclav Dry Syrup Read More ยป

Minoclav DT Tablets

๐Ÿ”ฌ Introduction Minoclav DT Tablets is a dispersible antibiotic tablet formulated to treat mild to moderate bacterial infections. With a powerful combination of Amoxycillin and Clavulanic Acid, it offers broad-spectrum protection while ensuring quick absorption for effective infection control. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Amoxycillin Bioavailability: ~70-90%โœ” Peak Plasma Concentration: Within 1-2 hoursโœ” Protein Binding:

Minoclav DT Tablets Read More ยป

World Health Day 2025: Promoting Global Health and Wellness with Minova Life Sciences

โœ… Introduction: Why is World Health Day Important? World Health Day, celebrated on April 7th every year, is a global initiative led by the World Health Organization (WHO). Established in 1950, it aims to raise awareness about critical health issues and promote better healthcare access worldwide. In 2025, this day carries even greater significance as

World Health Day 2025: Promoting Global Health and Wellness with Minova Life Sciences Read More ยป

Minoclav 625 Tablets

๐Ÿ”ฌ Introduction Minoclav 625 Tablets is a broad-spectrum antibiotic that combines Amoxycillin, a beta-lactam antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. This powerful combination ensures effective treatment against antibiotic-resistant bacterial infections in the respiratory, urinary, and gastrointestinal tracts. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Absorption: Rapidly absorbed from the gastrointestinal tractโœ” Bioavailability: Amoxycillin (~75%), Clavulanic Acid

Minoclav 625 Tablets Read More ยป

Minoclav 375 Tablets

๐Ÿ”ฌ Introduction Minoclav 375 Tablets is a broad-spectrum antibiotic that effectively combats bacterial infections. The combination of Amoxycillin (a penicillin-class antibiotic) and Clavulanic Acid (a beta-lactamase inhibitor) ensures enhanced effectiveness against resistant bacterial strains. This formulation is commonly used for mild to moderate bacterial infections across various body systems. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Amoxycillin

Minoclav 375 Tablets Read More ยป

Minoclav – 1.2G Injection

๐Ÿ”ฌ Introduction Minoclav – 1.2G Injection is a broad-spectrum intravenous antibiotic designed for the treatment of severe bacterial infections. With Amoxycillin, a beta-lactam antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor, it effectively combats antibiotic-resistant infections. This combination is commonly used in hospital settings for critically ill patients requiring intravenous (IV) administration. โš•๏ธ Pharmacokinetics & Bioavailability

Minoclav – 1.2G Injection Read More ยป

Meronorm 1000 Injection

๐Ÿ”ฌ Introduction Meronorm 1000 Injection is a broad-spectrum carbapenem antibiotic designed for the treatment of severe bacterial infections. Meropenem is a potent beta-lactam antibiotic that effectively combats Gram-positive, Gram-negative, and anaerobic bacteria. It is highly resistant to beta-lactamase enzymes, making it an excellent choice for multi-drug resistant infections. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Bioavailability: 100%

Meronorm 1000 Injection Read More ยป

Meronorm 500 Injection

Meronorm 500 Injection is a broad-spectrum carbapenem antibiotic used to treat serious bacterial infections. Meropenem is a beta-lactam antibiotic that effectively targets Gram-positive, Gram-negative, and anaerobic bacteria. It is highly stable against beta-lactamase enzymes, making it a strong choice for resistant infections. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Bioavailability: 100% (IV administration)โœ” Peak Plasma Concentration: Within

Meronorm 500 Injection Read More ยป

Matchfix-LB 200 Tablets

๐Ÿ”ฌ Introduction Matchfix-LB 200 Tablets combine Cefixime, a third-generation cephalosporin antibiotic, with Lactic Acid Bacillus, a probiotic that helps maintain gut flora balance. This dual-action formulation ensures effective bacterial infection control while preventing antibiotic-associated diarrhea and gut disturbances. โš•๏ธ Pharmacokinetics & Bioavailability โœ” Cefixime Bioavailability: ~40-50% (Absorption unaffected by food)โœ” Peak Plasma Concentration: Within 3-4

Matchfix-LB 200 Tablets Read More ยป

Scroll to Top